Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 5, 2011, Pages 2064-2069

  Tao, Zhengxian ^a   Chen, Bo ^a   Tan, Xiao ^a   Zhao, Yingming ^a   Wang, Liansheng ^a   Zhu, Tiebing ^a   Cao, Kejiang ^a   Yang, Zhijian ^a   Kan, Yuet Wai ^b   Su, Hua ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary disease; Gene therapy

Indexed keywords

ANGIOPOIETIN 1; BETA GALACTOSIDASE; CASPASE 3; HYPOXIA INDUCIBLE FACTOR; PARVOVIRUS VECTOR; PROTEIN BAD; PROTEIN BCL XL; PROTEIN KINASE B; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; WESTERN BLOTTING;

ANGIOPOIETIN-1; ANIMALS; CELL PROLIFERATION; CORONARY VESSELS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; CYTOMEGALOVIRUS; SUS;

EID: 79952167895     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1018925108     Document Type: Article

References (35)

1. Schumacher B, Pecher P, von Specht BU, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97:645-650. (Pubitemid 28090957)
2. Giordano FJ, et al. (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 2:534-539. (Pubitemid 26151517)
3. Harada K, et al. (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94:623-630. (Pubitemid 24250992)
4. Zhou L, et al. (2005) VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 12:196-202. (Pubitemid 40220621)
5. Pearlman JD, et al. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1:1085-1089.
6. Losordo DW, et al. (1998) Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804. (Pubitemid 29003959)
7. Takeshita S, et al. (1994) Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90:II228-II234.
8. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM (1998) Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98:2081-2087. (Pubitemid 28512235)
9. Yang ZJ, et al. (2006) Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther 13:1564-1568.
10. WangW, et al. (2006) Induction of collateral artery growth and improvement of postinfarct heart function by hepatocyte growth factor gene transfer. Acta Pharmacol Sin 27:555-560.
11. Su H, et al. (2009) Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart. Int J Cardiol 133:191-197.
12. Su H, Lu R, Kan YW (2000) Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 97:13801-13806.
13. Su H, Arakawa-Hoyt J, Kan YW (2002) Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 99:9480-9485. (Pubitemid 34764639)
14. Su H, et al. (2004) Adeno-associated viral vector delivers cardiac-specific and hypoxiainducible VEGF expression in ischemic mouse hearts. Proc Natl Acad Sci USA 101:16280-16285. (Pubitemid 39552836)
15. Su H, et al. (2006) AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Gene Ther 13:1495-1502. (Pubitemid 44567147)
16. Kajstura J, et al. (1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95:8801-8805. (Pubitemid 28350569)
17. Engel FB, Hsieh PC, Lee RT, Keating MT (2006) FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA 103:15546-15551. (Pubitemid 44625629)
18. Chaudhry HW, et al. (2004) Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem 279:35858-35866. (Pubitemid 39100593)
19. Nakajima H, Nakajima HO, Tsai SC, Field LJ (2004) Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res 94:1606-1614. (Pubitemid 38856968)
20. Woo YJ, et al. (2006) Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 114 (Suppl 1):I206-I213. (Pubitemid 44297152)
21. Tamamori-Adachi M, et al. (2008) Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. Cardiovasc Res 80:181-190.
22. Gill M, et al. (2001) Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88:167-174. (Pubitemid 32147304)
23. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK (1992) A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 86(Suppl 6):III47-III52.
24. Lee RJ, et al. (2000) VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102:898-901.
25. Schwarz ER, et al. (2000) Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. J Am Coll Cardiol 35:1323-1330. (Pubitemid 30206908)
26. Matsuno H, et al. (2002) Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 100:2487-2493.
27. Kaye DM, Hoshijima M, Chien KR (2008) Reversing advanced heart failure by targeting Ca2+ cycling. Annu Rev Med 59:13-28. (Pubitemid 351287921)
28. Hoshijima M, et al. (2002) Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8:864-871.
29. Klocke FJ, et al. (2003) ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 42:1318-1333. (Pubitemid 37188362)
30. Gude N, et al. (2006) Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 99:381-388. (Pubitemid 44253694)
31. Kornowski R, Fuchs S, Leon MB, Epstein SE (2000) Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 101:454-458. (Pubitemid 30067404)
32. Mack CA, et al. (1998) Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 115:168-176.
33. Matsushita T, et al. (1998) Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther 5:938-945. (Pubitemid 28371911)
34. Cerqueira MD, et al. (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539-542. (Pubitemid 34262671)
35. Poornima IG, et al. (2004) Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol 43:194-199. (Pubitemid 38201144)